Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2014
09/17/2014EP2776068A1 In-situ cross-linkable polymeric compositions and methods thereof
09/17/2014EP2776067A1 Composition for photodynamic diagnosis and treatment of tumors
09/17/2014EP2776044A1 Pharmaceutical compositions comprising lubricants for preventing or reducing aseptic loosening in a subject
09/17/2014EP2775838A1 Aqueous antimicrobial composition containing coniferous resin acids
09/16/2014US8835611 Calicheamicin derivative-carrier conjugates
09/16/2014US8835601 Natriuretic polypeptide delivery systems
09/16/2014US8835599 Segmented degradable polymers and conjugates made therefrom
09/16/2014US8835571 Fatty acid derivative-polymer conjugate
09/16/2014US8835556 Hydrolytically stable maleimide-terminated polymers
09/16/2014US8835525 Chain-extended polysiloxane crosslinkers with dangling hydrophilic polymer chains
09/16/2014US8835514 Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same
09/16/2014US8835513 Drug delivery devices
09/16/2014US8835509 Self emulsifying drug delivery system for a curcuminoid based composition
09/16/2014US8835508 Stable aqueous solution containing sodium pyruvate, and the preparation and use thereof
09/16/2014US8835505 Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container
09/16/2014US8835501 Pharmaceutical formulations of HDAC inhibitors
09/16/2014US8835479 Agent for fungal dermatitis
09/16/2014US8835414 Treatment of vaginal atrophy in women with cardiovascular pathology risk
09/16/2014US8835407 Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
09/16/2014US8835394 Treatment for basal cell carcinoma
09/16/2014US8835388 Polymer von Willebrand factor-conjugates
09/16/2014US8835380 Therapeutic conjugates
09/16/2014US8835379 Derivatives of CGRP
09/16/2014US8835377 Oral delivery of peptide pharmaceutical compositions
09/16/2014US8835376 Process for making particles for delivery of drug nanoparticles
09/16/2014US8834932 Anticoagulant-conjugated carbon nanocapsule, antithrombotic agent containing thereof
09/16/2014US8834927 Thermogelling anaesthetic compositions
09/16/2014US8834926 Macromolecular diffusion and release from self-assembled β-hairpin peptide hydrogels
09/16/2014US8834925 Tamper resistant dosage forms
09/16/2014US8834921 Sustained-release liposomal anesthetic compositions
09/16/2014US8834918 Modified multilayered film
09/16/2014US8834903 Nanoemulsion based on sugar fatty esters or on sugar fatty ethers and its uses in the cosmetics, dermatological and/or ophthalmological fields
09/16/2014US8834890 Siderophore conjugate immunogenic compositions and vaccines
09/16/2014US8834889 Antigen presenting composition and use thereof
09/16/2014US8834887 Drug for suppressing pathogen occurring in vivo
09/16/2014US8834886 Camptothecin-binding moiety conjugates
09/16/2014US8834885 Methods for identification of sites for IgG conjugation
09/16/2014US8834884 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
09/16/2014US8834883 Anti-VEGF antibodies and uses thereof
09/16/2014US8834871 Immunoglobulin molecules with improved characteristics
09/16/2014US8834861 Polycarbonates for delivery of drugs and methods of preparation thereof
09/16/2014US8834849 Medicinal aerosols and methods of delivery thereof
09/16/2014US8834842 Vitamin-targeted imaging agents
09/16/2014CA2787097C Low viscosity liquid polymeric delivery system
09/16/2014CA2753641C Bendamustine cyclopolysaccharide compositions
09/16/2014CA2677842C Pharmaceutical composition comprising microparticle oily suspension
09/16/2014CA2650342C Chromium complexes
09/16/2014CA2633040C Composition of inverse emulsion type comprising ivermectin, and uses thereof in cosmetics and dermatology
09/16/2014CA2624081C Method of identifying membrane ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells
09/16/2014CA2611831C A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
09/16/2014CA2527750C A dried product and a process for manufacturing the product
09/12/2014WO2014138603A1 Stabilization of moisture-sensitive drugs
09/12/2014WO2014138437A1 Steroid conjugates
09/12/2014WO2014138425A1 Cyclosporine a-steroid conjugates
09/12/2014WO2014138403A1 Antibiotic conjugates
09/12/2014WO2014138375A1 Antibiotic conjugates linked with steroid drugs
09/12/2014WO2014138359A1 Steroid antibiotic conjugates
09/12/2014WO2014138350A1 Antibiotic conjugates directly linked with steroid drugs
09/12/2014WO2014138343A1 Antibiotic conjugates with nonsteroidal anti-inflammatory drugs
09/12/2014WO2014138319A2 Pharmaceutical composition comprising albumin-binding arginine deiminase for cancer targeting treatment
09/12/2014WO2014138278A1 Lipid bilayer coated mesoporous silica nanoparticles with a high loading capacity for one or more anticancer agents
09/12/2014WO2014138241A1 Pharmaceuticals for oral delivery
09/12/2014WO2014138186A1 Bioorthogonal two-component delivery systems for enhanced internalization of nanotherapeutics
09/12/2014WO2014138085A1 Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocular drug delivery
09/12/2014WO2014138018A1 Preservative free bimatoprost and timolol solutions
09/12/2014WO2014137050A1 Porous microparticles in which trail is surface modified and chemical anticancer drug is incorporated, and preparation method therefor
09/12/2014WO2014136944A1 Aqueous liquid composition including high concentration of l-histidine
09/12/2014WO2014136857A1 Coating composition, coated preparation and method for producing same
09/12/2014WO2014136717A1 Transdermally absorbable pharmaceutical composition
09/12/2014WO2014136494A1 Enteric-coated fine particle and drug composition
09/12/2014WO2014136048A1 Formulations of organic compounds
09/12/2014WO2014135967A1 Curcumin solid lipid particles and methods for their preparation and use
09/12/2014WO2014135965A1 Bismuth liquid filled hard capsules
09/12/2014WO2014135841A1 Nanoparticle peptide compositions
09/12/2014WO2014135840A1 Nanoparticle peptide compositions
09/12/2014WO2014135691A1 Compound-carrier systems for assays in nematodes
09/12/2014WO2014135282A1 Amatoxin derivatives
09/12/2014WO2014135123A1 17α-ethynyl-androst-5-ene-3β,7β,17β-triol ophthalmic preparation
09/12/2014WO2014134922A1 Meloxicam eye drops and preparation method and use thereof
09/12/2014WO2014134698A1 Cpg oligonucleotide formulations and methods and uses thereof
09/11/2014US20140257100 Porphyrin Microbubbles
09/11/2014US20140256957 N-Maleimidyl Polymer Derivatives
09/11/2014US20140256833 Mild leave-on skin care compositions
09/11/2014US20140256832 Fullerene-derived cellulose nanocrystal, their preparation and uses thereof
09/11/2014US20140256831 Hydrogel and method for producing same
09/11/2014US20140256828 Stable liquid formulations of volatile gas anesthetics
09/11/2014US20140256785 Site specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
09/11/2014US20140256783 Substrate and method for production thereof
09/11/2014US20140256772 Pharmaceutical compositions that inhibit disproportionation
09/11/2014US20140256764 Tamper resistant dosage form comprising an adsorbent and an adverse agent
09/11/2014US20140256749 Methods and compositions for transdermal delivery of caffeine in the form of solutions or suspensions
09/11/2014US20140256696 Steroid conjugates
09/11/2014US20140256694 Steroid antibiotic conjugates
09/11/2014US20140256689 Petroleum jelly-free unguent compositions comprising vitamin d compounds and optionally steroidal anti-inflammatory agents
09/11/2014US20140256675 Ophthalmic compositions and methods for treating eyes
09/11/2014US20140256666 Antibiotic conjugates with nonsteroidal anti-inflammatory drugs
09/11/2014US20140256660 Antibiotic conjugates linked with steroid drugs
09/11/2014US20140256658 Antibiotic Conjugates
09/11/2014US20140256652 Polypeptides Involved In Immune Response
09/11/2014US20140256651 Cyclosporine A steroid conjugates
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 1712